THYMIC EPITHELIAL TUMOR
Clinical trials for THYMIC EPITHELIAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new THYMIC EPITHELIAL TUMOR trials appear
Sign up with your email to follow new studies for THYMIC EPITHELIAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare thymus cancers: PT-112 trial launches
Disease control Recruiting nowThis study tests a drug called PT-112 in people with thymoma or thymic cancer that has come back or worsened after standard treatment. PT-112 is designed to kill cancer cells and boost the immune system. About 53 adults will receive the drug intravenously in 28-day cycles. The ma…
Matched conditions: THYMIC EPITHELIAL TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Scientists dive deep into thymic tumors to unlock new clues
Knowledge-focused Recruiting nowThis study looks at thymic epithelial tumors, a rare type of cancer in the chest. Researchers will collect tumor and blood samples from 50 patients during surgery to analyze the immune cells and genetic changes in the tumors. The goal is to better understand the disease and ident…
Matched conditions: THYMIC EPITHELIAL TUMOR
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:16 UTC